CorePlus Using AI to Enhance Cervical Cancer Screenings
CorePlus, a pathology-focused company, has announced that it became the first laboratory globally to operationalize the Techcyte AI algorithm and quality control workflow for cytology-based cervical cancer screening.
Their press release stated that after more than two years of clinical collaboration with Techcyte, CorePlus has achieved the precision and accuracy necessary to deploy this tool. The results show that the AI is providing 100% quality control of all Pap tests, exceeding regulatory mandates.
Get your ODSC Europe 2024 pass today!
In-Person and Virtual Conference
September 5th to 6th, 2024 — London
Featuring 200 hours of content, 90 thought leaders and experts, and 40+ workshops and training sessions, Europe 2024 will keep you up-to-date with the latest topics and tools in everything from machine learning to generative AI and more.
Mariano de Socarraz, Founder and CEO of CorePlus, emphasized the importance of inclusivity in algorithm validation. “We are fortunate to have included Puerto Rican women in the validation of the algorithm. Ethnic diversity is key to eliminating potential algorithmic bias. Including this subset of the population ensures that Hispanic women are well represented. This is crucial as Hispanics are becoming a significant percentage of the US population.”
Cervical cancer incidence in Puerto Rican women increased from 9.2 to 13 cases per 100,000 between 2001 and 2017. Early detection is vital for providing therapeutic intervention, enhancing quality of life, and reducing healthcare costs.
Dr. Juan C. Santa-Rosario, CorePlus’ Chief Medical Officer, highlighted the rigorous validation process. “Our study included digitization of more than 1,500 cases scanned on the Epredia P1000 with water immersion at different modalities. Conducted by Dr. María del Mar Rivera-Rolón, our Board-Certified Cytopathologist, we can now review 100% of Pap tests processed at our laboratory using the Techcyte AI-assisted tool. This will provide more accurate results and promote patient safety.”
Ben Cahoon, CEO of Techcyte, expressed enthusiasm about the collaboration. “CorePlus is one of the most innovative organizations in the world at implementing digital pathology solutions. We are thrilled they will be using our AI-based cervical cytology software to impact women’s health in Puerto Rico and globally. We appreciate their collaboration and shared mission to positively impact lab professionals and the patients they serve.”
In a statement, CorePlus mentioned that it was dedicated to deploying new and disruptive technologies for the benefit of patients, physicians, and the healthcare ecosystem. Since 2020 the company has worked to help transform pathology to digital pathology and the use of AI algorithms.
ODSC West 2024 tickets available now!
In-Person & Virtual Data Science Conference
October 29th-31st, 2024 — Burlingame, CA
Join us for 300+ hours of expert-led content, featuring hands-on, immersive training sessions, workshops, tutorials, and talks on cutting-edge AI tools and techniques, including our first-ever track devoted to AI Robotics!
As a high complexity CLIA-certified laboratory with facilities in Carolina and Ponce, Puerto Rico, CorePlus has implemented and validated AI-powered solutions following CLIA laboratory-developed test (LDT) regulations and College of American Pathology (CAP) guidelines.
Originally posted on OpenDataScience.com
Read more data science articles on OpenDataScience.com, including tutorials and guides from beginner to advanced levels! Subscribe to our weekly newsletter here and receive the latest news every Thursday. You can also get data science training on-demand wherever you are with our Ai+ Training platform. Interested in attending an ODSC event? Learn more about our upcoming events here.
